Kasiak Research

Mumbai, India Founded: 2009 • Age: 17 yrs
Develops innovative stem cell-based therapies for treating diabetic foot ulcers.
Annual revenue $25,376 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 7 Brand Intelligence

About Kasiak Research

Kasiak Research is a company based in Mumbai (India) founded in 2009. It operates as a B2B. Kasiak Research operates in a competitive market with competitors including BiomX, Aurealis Therapeutics, NovaLead Pharma, Paracrine and CellResearch Therapeutics, among others.

  • Headquarter Mumbai, India
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Kasiak Research Private Limited Cn
  • Date of Incorporation 16 May, 2005
  • Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Healthcare → Healthcare Education, Research & Associations Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $25.38 K (USD)
    -49.53
    as on Mar 31, 2017
  • Net Profit
    -$62.37 K (USD)
    64.01
    as on Mar 31, 2017
  • EBITDA
    -$47.39 K (USD)
    67.97
    as on Mar 31, 2017
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Kasiak Research

Premium access

Detailed funding history for Kasiak Research

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kasiak Research

Investments
Premium access

Investment portfolio details for Kasiak Research

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Kasiak Research

Premium access

Detailed financials for Kasiak Research

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kasiak Research Comparisons

Kasiak Research Primary company
Description
Develops innovative stem cell-based therapies for treating d...
Location
Mumbai, India
Founded Year
2009
Annual Revenue
$25.38 K (USD)
Net Profit
-$62.37 K (USD)
EBITDA
-$47.39 K (USD)
Employees
Not available
Premium access

Peer comparison for Kasiak Research

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Kasiak Research

Kasiak Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BiomX, Aurealis Therapeutics, NovaLead Pharma, Paracrine and CellResearch Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Microbiome therapeutics are developed for dysbiosis-linked diseases.
Locked Locked Locked
Provider of cell & gene therapy platforms for chronic wounds, cancer, and inflammatory diseases
Locked Locked Locked
Drug repurposing and discovery are enabled by a proprietary platform.
Locked Locked Locked
Therapeutics for diabetic foot ulcers are developed.
Locked Locked Locked
Pioneers stem cell research for treatments of diabetic foot ulcers and hair loss conditions.
Locked Locked Locked
It creates innovative technologies of molecular therapeutics for tissue regeneration.
Premium access

Detailed competitors of Kasiak Research

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kasiak Research

Premium access

Complete news archive for Kasiak Research

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kasiak Research

Kasiak Research was founded in 2009.

Kasiak Research is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Annual revenue of Kasiak Research is $25.38K as on Mar 31, 2017.

Kasiak Research develops innovative stem cell-based therapies for treating diabetic foot ulcers, focusing on providing healthcare solutions, advancing biotech innovations, conducting medical research, and therapeutics development. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Kasiak Research's top competitors include BiomX, Aurealis Therapeutics and NovaLead Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available